Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 6051-6100 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05879744
A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)
PHASE1
Active, not recruiting
90 participants
Started: May 31, 2023 · Completed: Apr 30, 2027
2 conditions
1 sponsor
6 locations
NCT05882877
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
PHASE3
Active, not recruiting
2,621 participants
Started: May 31, 2023 · Completed: Jun 2, 2027
1 condition
1 sponsor
547 locations
NCT05859438
INcorporating VoIce AcTivated Communication Aids Into Everyday Communication
NA
Active, not recruiting
30 participants
Started: May 31, 2023 · Completed: Apr 30, 2025
1 condition
2 sponsors
1 location
NCT05877716
EPI-MINN: Targeting Cognition and Motivation - National
NA
Active, not recruiting
200 participants
Started: May 30, 2023 · Completed: Jun 30, 2026
11 conditions
2 sponsors
1 location
NCT05728034
Information Seeking About Pre-exposure Prophylaxis
NA
Active, not recruiting
675 participants
Started: May 30, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT06082700
Correlation Between Missing Posterior Teeth and Vertical Dimension Measurements With Temporomandibular Joint Disorders in a Sample of Adult Egyptian Subjects
N/A
Active, not recruiting
93 participants
Started: May 30, 2023 · Completed: Feb 29, 2024
1 condition
1 sponsor
1 location
NCT05846672
"Turkish Cultural Adaptation, Validity and Reliability of the Gait Outcomes Assessment List"
N/A
Active, not recruiting
200 participants
Started: May 30, 2023 · Completed: Dec 30, 2023
4 conditions
1 sponsor
1 location
NCT05882045
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
PHASE3
Active, not recruiting
1,800 participants
Started: May 30, 2023 · Completed: May 31, 2026
2 conditions
1 sponsor
169 locations
NCT06165913
"The Evaluation of Facial Bone Changes After Early Implant Placement Protocols Clinically and Radiographically."
NA
Active, not recruiting
22 participants
Started: May 30, 2023 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05850351
Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic Fibrosis
NA
Active, not recruiting
36 participants
Started: May 30, 2023 · Completed: Sep 30, 2025
3 conditions
2 sponsors
1 location
NCT06913634
Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase
N/A
Active, not recruiting
140 participants
Started: May 30, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05765851
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
PHASE1
Active, not recruiting
78 participants
Started: May 30, 2023 · Completed: Jun 30, 2026
2 conditions
2 sponsors
8 locations
NCT05889676
Validation of a Simultaneous Ocular/Cervical VEMP With Mastoid Vibration by B250
N/A
Active, not recruiting
120 participants
Started: May 30, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05819775
CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema
PHASE3
Active, not recruiting
20 participants
Started: May 30, 2023 · Completed: Dec 10, 2025
1 condition
1 sponsor
13 locations
NCT06587074
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
N/A
Active, not recruiting
150 participants
Started: May 30, 2023 · Completed: Jul 22, 2025
1 condition
1 sponsor
1 location
NCT06112808
A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
PHASE1
Active, not recruiting
300 participants
Started: May 29, 2023 · Completed: Jan 31, 2027
1 condition
1 sponsor
30 locations
NCT05809830
Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
PHASE1/PHASE2
Active, not recruiting
152 participants
Started: May 29, 2023 · Completed: May 8, 2026
1 condition
1 sponsor
6 locations
NCT06285370
A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy
PHASE4
Active, not recruiting
23 participants
Started: May 29, 2023 · Completed: Nov 13, 2025
1 condition
1 sponsor
8 locations
NCT05809531
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
PHASE3
Active, not recruiting
100 participants
Started: May 29, 2023 · Completed: Jul 31, 2027
12 conditions
1 sponsor
47 locations
NCT05680805
Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS
PHASE4
Active, not recruiting
100 participants
Started: May 27, 2023 · Completed: Nov 30, 2025
2 conditions
2 sponsors
1 location
NCT05608837
Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
PHASE2
Active, not recruiting
28 participants
Started: May 26, 2023 · Completed: Sep 30, 2026
2 conditions
3 sponsors
8 locations
NCT05825625
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
PHASE2
Active, not recruiting
35 participants
Started: May 26, 2023 · Completed: Jun 1, 2027
1 condition
3 sponsors
2 locations
NCT05590468
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy
PHASE2
Active, not recruiting
34 participants
Started: May 26, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05862584
Impact of Air Pollution on the Course of Inflammatory Rheumatism
NA
Active, not recruiting
86 participants
Started: May 26, 2023 · Completed: Dec 30, 2024
3 conditions
1 sponsor
1 location
NCT05674422
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
N/A
Active, not recruiting
120 participants
Started: May 26, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
15 locations
NCT05878288
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
PHASE2
Active, not recruiting
11 participants
Started: May 26, 2023 · Completed: May 31, 2029
4 conditions
6 sponsors
1 location
NCT06014892
The 4th Trimester Initiative: The Impact of Parental Support on Pregnant Trainee Wellbeing
NA
Active, not recruiting
152 participants
Started: May 25, 2023 · Completed: Dec 31, 2025
3 conditions
4 sponsors
4 locations
NCT05822245
A Study of PER-001 in Participants With Open-Angle Glaucoma
PHASE1/PHASE2
Active, not recruiting
36 participants
Started: May 25, 2023 · Completed: Apr 4, 2026
1 condition
1 sponsor
1 location
NCT05867615
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
PHASE2
Active, not recruiting
83 participants
Started: May 25, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
2 locations
NCT05885464
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
PHASE1/PHASE2
Active, not recruiting
5 participants
Started: May 25, 2023 · Completed: Dec 31, 2026
3 conditions
1 sponsor
10 locations
NCT06148675
Macrowire for IntracraNial Thrombectomy
N/A
Active, not recruiting
200 participants
Started: May 25, 2023 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT06606548
Comprehensive Oral Care Long-term Care Facilities
NA
Active, not recruiting
100 participants
Started: May 25, 2023 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05699772
Expanding Delivery of an Evidence-based Weight-loss Intervention to Enhance Access and Reach Underserved Groups After TBI
NA
Active, not recruiting
85 participants
Started: May 25, 2023 · Completed: Aug 31, 2027
1 condition
3 sponsors
1 location
NCT05847790
Remote Pregnancy Monitoring to Improve Access
NA
Active, not recruiting
400 participants
Started: May 25, 2023 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05572359
Cryo and Compression Therapy After TKA and UKA
NA
Active, not recruiting
208 participants
Started: May 25, 2023 · Completed: Mar 31, 2026
1 condition
3 sponsors
1 location
NCT05660954
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
PHASE2
Active, not recruiting
41 participants
Started: May 25, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
9 locations
NCT05996783
Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial
NA
Active, not recruiting
48,000 participants
Started: May 25, 2023 · Completed: Sep 30, 2026
4 conditions
4 sponsors
1 location
NCT05873439
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
EARLY_PHASE1
Active, not recruiting
3 participants
Started: May 25, 2023 · Completed: Oct 31, 2026
4 conditions
1 sponsor
1 location
NCT05889143
A Study to Evaluate the Efficacy and Safety of CREZET Tablet
N/A
Active, not recruiting
15,000 participants
Started: May 24, 2023 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT05605509
RP-6306 in Patients With Advanced Cancer
PHASE2
Active, not recruiting
28 participants
Started: May 24, 2023 · Completed: May 31, 2026
1 condition
2 sponsors
6 locations
NCT06863870
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
N/A
Active, not recruiting
35 participants
Started: May 24, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT05758480
Characterization of the Immunometabolic Signature in Long COVID-19.
NA
Active, not recruiting
100 participants
Started: May 24, 2023 · Completed: Nov 3, 2025
1 condition
1 sponsor
1 location
NCT05299125
Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations
PHASE2
Active, not recruiting
54 participants
Started: May 24, 2023 · Completed: Jul 31, 2027
1 condition
2 sponsors
14 locations
NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
PHASE4
Active, not recruiting
2,005 participants
Started: May 23, 2023 · Completed: Dec 1, 2027
11 conditions
2 sponsors
1 location
NCT05717270
Two-layer Suturing of Achilles Tendon Ruptures
N/A
Active, not recruiting
23 participants
Started: May 23, 2023 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT05812144
New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular Dystrophy
NA
Active, not recruiting
70 participants
Started: May 23, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
3 locations
NCT06715592
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study
PHASE2
Active, not recruiting
18 participants
Started: May 23, 2023 · Completed: Feb 1, 2027
2 conditions
1 sponsor
1 location
NCT06279091
Correlation of Children and Parental Anxiety and Effectiveness of Breathing Exercises on Anxiety Reduction
NA
Active, not recruiting
90 participants
Started: May 23, 2023 · Completed: May 23, 2024
1 condition
1 sponsor
1 location
NCT05718557
Study of PYX-106 in Solid Tumors
PHASE1
Active, not recruiting
47 participants
Started: May 23, 2023 · Completed: May 31, 2026
1 condition
1 sponsor
20 locations
NCT05687890
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
PHASE2
Active, not recruiting
255 participants
Started: May 23, 2023 · Completed: Apr 30, 2025
2 conditions
1 sponsor
1 location
Previous
1
More pages
119
120
121
122
123
124
125
More pages
431
Next